Diagnosis and Evaluation of Adrenal Mass: Difference between revisions
Urology4all (talk | contribs) No edit summary |
Urology4all (talk | contribs) |
||
Line 30: | Line 30: | ||
=== UrologySchool.com Summary === | === UrologySchool.com Summary === | ||
* '''<span style="color:#ff0000">History and | * '''<span style="color:#ff0000">History and Physical Exam</span>''' | ||
* '''<span style="color:#ff0000">Labs (3)</span>'''[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3147036/ §] | * '''<span style="color:#ff0000">Labs (3)</span>'''[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3147036/ §] | ||
*# '''<span style="color:#ff0000">Low-dose dexamethasone suppression test or 24-hour urinary cortisol to rule out hypercortisolism AND</span>''' | *# '''<span style="color:#ff0000">Low-dose dexamethasone suppression test or 24-hour urinary cortisol to rule out hypercortisolism AND</span>''' | ||
Line 50: | Line 38: | ||
*#'''<span style="color:#ff0000">Unenhanced CT</span>''' | *#'''<span style="color:#ff0000">Unenhanced CT</span>''' | ||
*#* '''<span style="color:#ff0000">If attenuation ≥ 10HU, obtain contrast enhanced CT with adrenal washout</span>''' | *#* '''<span style="color:#ff0000">If attenuation ≥ 10HU, obtain contrast enhanced CT with adrenal washout</span>''' | ||
=== History and Physical Exam === | |||
*'''Most patients are asymptomatic''' | |||
*'''<span style="color:#ff0000">Screen for signs and symptoms related to disorders of</span>''' | |||
** '''<span style="color:#ff0000">Adrenal hyperfunction</span>''' | |||
**# '''<span style="color:#ff0000">Hypercortisolism (9)</span>''' | |||
**##'''<span style="color:#ff0000">Central obesity</span>''' | |||
**##'''<span style="color:#ff0000">Moon facies</span>''' | |||
**##'''<span style="color:#ff0000">Buffalo hump</span>''' | |||
**##'''<span style="color:#ff0000">Facial plethora</span>''' | |||
**##'''<span style="color:#ff0000">Menstrual disturbances</span>''' | |||
**##'''<span style="color:#ff0000">Hirsuitism</span>''' | |||
**##'''<span style="color:#ff0000">Proximal muscle weakness</span>''' | |||
**##'''<span style="color:#ff0000">Easy bruisability</span>''' | |||
**##'''<span style="color:#ff0000">Abdominal striae</span>''' | |||
**##'''<span style="color:#ff0000">Systemic manifestations include dyslipidemia, insulin resistance, and hypertension</span>''' | |||
**# '''<span style="color:#ff0000">Hyperaldosteronism: hypertension</span>''' | |||
**#*Hypertension classified as | |||
**#** Elevated blood pressure: SBP 120-129 mm Hg; DBP < 80 mm Hg | |||
**#** Stage 1 hypertension: SBP 130 - 139 mm Hg; DBP 80 - 89 mm Hg | |||
**#** Stage 2 hypertension: SBP ≥140 mm Hg; DBP ≥ 90 mm Hg | |||
**# '''<span style="color:#ff0000">Pheochromocytoma (3):</span>''' | |||
**##'''<span style="color:#ff0000">Headache</span>''' | |||
**##'''<span style="color:#ff0000">Episodic sudden perspiration</span>''' | |||
**##'''<span style="color:#ff0000">Tachycardia</span>''' | |||
**# '''<span style="color:#ff0000">Adrenal sex steroid hypersecretion</span>''' | |||
** '''<span style="color:#ff0000">Adrenal malignancy</span>''' | |||
=== Labs === | === Labs === |